Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

Original reporting
Published Aug 12, 2026, 2:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ambiq (AMBQ) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AMBQBullishHigh
01

Why it matters

Traders can update models using the newly stated Q3 revenue range ($36M to $37M) and full-year net sales guidance (about $135M), while stress-testing for shipment delays due to wafer, packaging, substrate, and testing capacity constraints.

02

Market read

Fresh guidance and margin/cash details plus a clear supply-capacity headwind create a tradable setup for near-term estimates and positioning.

03

What to watch

The call notes higher R&D and SG&A tied to IP licensing and public-company costs; if gross margin expansion stalls, operating leverage may be less favorable than implied.

Relevance 9/10Novelty 9/10Timing: pre-market/early trading today after Q2 2026 earnings call

Background

Ambiq’s Q2 2026 earnings call focused on edge-AI demand, product ramp progress (Apollo/Atomiq families), and explicit second-half supply capacity limits.

Company-level read

Ticker impact

$AMBQBullishHigh confidence
Context

Ambiq guided full-year net sales to about $135M and Q3 revenue to $36M to $37M amid edge-AI demand and supply constraints.

Expected impact

Near-term bias likely positive on guidance and gross margin expansion, but tempered by explicit wafer, packaging, and testing capacity headwinds.

Evidence & confidence

The article discloses specific Q2 results, full-year and Q3 revenue ranges, gross margin expansion, and management-identified supply bottlenecks that directly affect near-term revenue realization.

Market effects

Highlights ongoing edge-AI semiconductor supply bottlenecks (wafers, packaging, testing) that can affect peers’ fulfillment and revenue timing.

China exposure rose to 14% of net sales, which may matter for regional demand sensitivity and any export or demand shocks.

Reinforces that AI compute content growth in devices is driving demand for ultra-low-power SoCs, but capacity limits can cap second-half shipments.

Counterpoint

Supply constraints could cause demand to spill into later quarters, making the $135M full-year target optimistic if capacity does not loosen.

Key entities

  • Ambiq Micro, Inc.

    Reported Q2 2026 results and issued Q3 and full-year guidance, citing supply constraints and edge-AI demand acceleration.

  • Fumihide Esaka

    CEO who discussed supply-constrained industry conditions and demand exceeding initial expectations for some products.

  • Jeffrey Winzeler

    CFO who discussed financial results, margin drivers, and cash/expense trends.

Related articles

$AMBQMed

Ambiq Q3 2026 slides: 110% revenue growth, margins expand to 48.7%

Ambiq Micro (AMBQ) reported Q3 2026 revenue growth of 110% YoY to $38.1M, with gross margins expanding to 48.7%. The company expects similar growth in Q4 and full-year sales of ~$140M. Despite beating earnings expectations, shares fell 4.09% premarket, reflecting investor concerns about profitability and execution risks. Ambiq highlighted its edge AI semiconductor business and product pipeline, including the upcoming Atomiq platform.

$AMBQMed

Ambiq Reports Third Quarter 2026 Financial Results

Ambiq Micro, Inc. (AMBQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ambiq Reports Third Quarter 2026 Financial Results Third quarter net sales increased 110% year-over-year on broad demand across customers, product families and form factors Gross profit more than doubled year-over-year, outpacing net sales growth Expect fourth quarter net sales o

$AMBQMed

Jefferies initiates Ambiq Micro stock with buy rating on AI edge computing potential

Jefferies initiated coverage on Ambiq Micro (NYSE: AMBQ) with a buy rating and $90 price target, citing its AI edge computing potential. The company's SPOT architecture offers power advantages for edge devices. Ambiq Micro reported 89.7% revenue growth in Q2, with full-year sales outlook raised to $135 million. Several analysts revised earnings upwards, and multiple firms increased price targets.

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.